Skip to main content
Erschienen in: Reactions Weekly 1/2021

01.07.2021 | Case report

Remdesivir/tocilizumab

Rebound of HCV viral load and loss of anti-HBs: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Da Cunha MR, et al. A case of severe acute respiratory syndrome coronavirus 2 treatment with remdesivir in a hepatitis C-Coinfected patient resulting in temporary viral control and posttreatment flare. Open Forum Infectious Diseases 8: No. 4, Apr 2021. Available from: URL: https://academic.oup.com/ofid Da Cunha MR, et al. A case of severe acute respiratory syndrome coronavirus 2 treatment with remdesivir in a hepatitis C-Coinfected patient resulting in temporary viral control and posttreatment flare. Open Forum Infectious Diseases 8: No. 4, Apr 2021. Available from: URL: https://​academic.​oup.​com/​ofid
Metadaten
Titel
Remdesivir/tocilizumab
Rebound of HCV viral load and loss of anti-HBs: case report
Publikationsdatum
01.07.2021
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2021
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-98548-0

Weitere Artikel der Ausgabe 1/2021

Reactions Weekly 1/2021 Zur Ausgabe

Case report

Multiple drugs

Case report

Topiramate

Case report

Methotrexate